Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: Cardiol Therapeutics Inc.

Baystreet - Tue Apr 14, 6:46AM CDT

Announced that Cardiol's President and Chief Executive Officer David Elsley, will participate in a live interview on X with Barchart.com today at 12:00 p.m. EDT. Cardiol Therapeutics Inc. shares T.CRDL are trading unchanged at $1.89.